Cardiovascular Research
| Name | Preis | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Polyclonal Antibody to Cyclooxygenase-2 (COX 2) | Anmelden | Polyclonal Antibody to Cyclooxygenase-2 (COX 2) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Cyclooxygenase-2 (COX 2) | Anmelden | Polyclonal Antibody to Cyclooxygenase-2 (COX 2) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Cyclooxygenase-2 (COX 2) | Anmelden | Polyclonal Antibody to Cyclooxygenase-2 (COX 2) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Caspase 3 (CASP3) | Anmelden | Polyclonal Antibody to Caspase 3 (CASP3) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Cyclooxygenase 1 (COX-1) | Anmelden | Polyclonal Antibody to Cyclooxygenase 1 (COX-1) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Caspase 12 (CASP12) | Anmelden | Polyclonal Antibody to Caspase 12 (CASP12) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Cyclooxygenase-2 (COX 2) | Anmelden | Polyclonal Antibody to Cyclooxygenase-2 (COX 2) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Alpha-1-Antichymotrypsin (a1ACT) | Anmelden | Polyclonal Antibody to Alpha-1-Antichymotrypsin (a1ACT) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Alpha-1-Antichymotrypsin (a1ACT) | Anmelden | Polyclonal Antibody to Alpha-1-Antichymotrypsin (a1ACT) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Caspase 10 (CASP10) | Anmelden | Polyclonal Antibody to Caspase 10 (CASP10) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Phospholipase A2, Group IID (PLA2G2D) | Anmelden | Polyclonal Antibody to Phospholipase A2, Group IID (PLA2G2D) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Interleukin 27 Receptor Alpha (IL27Ra) | Anmelden | Polyclonal Antibody to Interleukin 27 Receptor Alpha (IL27Ra) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Cholinergic Receptor, Muscarinic 4 (CHRM4) | Anmelden | Polyclonal Antibody to Cholinergic Receptor, Muscarinic 4 (CHRM4) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Prolylcarboxypeptidase (PRCP) | Anmelden | Polyclonal Antibody to Prolylcarboxypeptidase (PRCP) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Corticosteroid Binding Globulin (CBG) | Anmelden | Polyclonal Antibody to Corticosteroid Binding Globulin (CBG) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Corticosteroid Binding Globulin (CBG) | Anmelden | Polyclonal Antibody to Corticosteroid Binding Globulin (CBG) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Interleukin 27 Receptor Alpha (IL27Ra) | Anmelden | Polyclonal Antibody to Interleukin 27 Receptor Alpha (IL27Ra) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Adrenergic Receptor Alpha 1A (ADRa1A) | Anmelden | Polyclonal Antibody to Adrenergic Receptor Alpha 1A (ADRa1A) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Chymotrypsin C (CTRC) | Anmelden | Polyclonal Antibody to Chymotrypsin C (CTRC) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Prolylcarboxypeptidase (PRCP) | Anmelden | Polyclonal Antibody to Prolylcarboxypeptidase (PRCP) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Chymotrypsin C (CTRC) | Anmelden | Polyclonal Antibody to Chymotrypsin C (CTRC) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Mannose Receptor C Type 2 (MRC2) | Anmelden | Polyclonal Antibody to Mannose Receptor C Type 2 (MRC2) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Caspase 5 (CASP5) | Anmelden | Polyclonal Antibody to Caspase 5 (CASP5) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Angiotensinogen (AGT) | Anmelden | Polyclonal Antibody to Angiotensinogen (AGT) | ||||||||||||||||
|
||||||||||||||||||
| Polyclonal Antibody to Angiotensinogen (AGT) | Anmelden | Polyclonal Antibody to Angiotensinogen (AGT) | ||||||||||||||||
|
||||||||||||||||||


